Daniel M. Bollag
Keine laufenden Positionen mehr
Profil
Daniel M.
Bollag worked as a Director of Project Planning & Management at Bristol Myers Squibb Co. from 2000 to 2002, as a Director of US Regulatory Liaison at Sanofi-Aventis Pharmaceuticals from 2002 to 2006, as a Vice President of Regulatory Affairs at Genzyme Corp.
from 2006 to 2008, and as a Senior Vice President of Regulatory Affairs & Quality at ARIAD Pharmaceuticals, Inc. from 2009 to 2017 and at Ocular Therapeutix, Inc. from 2017 to 2019.
He also worked as a Senior Project Manager at Merck Research Laboratories Massachusetts LLC.
Bollag earned a doctorate degree from Cornell University and an undergraduate degree from The Pennsylvania State University.
Ehemalige bekannte Positionen von Daniel M. Bollag
| Unternehmen | Position | Ende |
|---|---|---|
| OCULAR THERAPEUTIX, INC. | General Counsel | 01.12.2019 |
| ARIAD PHARMACEUTICALS, INC. | General Counsel | 01.05.2017 |
Genzyme Corp.
 Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | General Counsel | 01.01.2008 |
| Sanofi-Aventis Pharmaceuticals | Corporate Officer/Principal | 01.01.2006 |
| BRISTOL-MYERS SQUIBB COMPANY | Corporate Officer/Principal | 01.01.2002 |
Ausbildung von Daniel M. Bollag
| The Pennsylvania State University | Undergraduate Degree |
| Cornell University | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| BRISTOL-MYERS SQUIBB COMPANY | Health Technology |
| OCULAR THERAPEUTIX, INC. | Health Technology |
| Private Unternehmen | 4 |
|---|---|
ARIAD Pharmaceuticals, Inc.
 ARIAD Pharmaceuticals, Inc. BiotechnologyHealth Technology ARIAD Pharmaceuticals, Inc. operates as an oncology company, which engages in the discovery, development, and commercialization of small-molecule drugs for the treatment of cancer. The company was founded by Harvey J. Berger and James E. Rothman on January 8, 1992 and is headquartered in Cambridge, MA. | Health Technology |
Genzyme Corp.
Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Health Technology |
| Sanofi-Aventis Pharmaceuticals | |
Merck Research Laboratories Massachusetts LLC
 Merck Research Laboratories Massachusetts LLC Pharmaceuticals: MajorHealth Technology Part of Merck & Co., Inc., Merck Research Laboratories Massachusetts LLC is a pharmaceutical company that provides free medicines and adult vaccines to qualified patients through their Merck Patient Assistance Program. The company is based in Boston, MA and is a part of Merck & Co., Inc. and its affiliates. The company also offers information about insurance coverage and financial assistance options for eligible patients. The company conducts clinical trials and provides medical information covering thousands of topics in all fields of medicine through their Merck Manuals. Additionally, they report on their commitment to operating responsibly to benefit society through their corporate responsibility program, which includes their environmental, social, and governance (ESG) report. Merck for Mothers is an initiative to create a world where no woman has to die giving life. | Health Technology |
